Form 4: Hillenbrand Interim CFO Reports RSU Awards
Insider Transaction Report
Hillenbrand's Interim CFO, Megan A. Walke, reported the acquisition of restricted stock units and her total beneficial ownership of common stock and derivatives.
Summary
- Megan A. Walke, Interim CFO, VP, CC, & CAO of Hillenbrand, Inc. (HI), filed a Form 4 statement regarding changes in her beneficial ownership.
- On December 31, 2025, Ms. Walke acquired 6 Restricted Stock Units (RSUs) from an award dated December 7, 2023.
- On December 31, 2025, she also acquired 16 RSUs from an award dated December 5, 2024.
- Additionally, on December 31, 2025, Ms. Walke acquired 50 RSUs from an award dated December 4, 2025.
- Each RSU represents the contingent right to receive one share of Hillenbrand's common stock and is entitled to dividend equivalent rights.
- Following these transactions, Ms. Walke directly beneficially owns 6,423 shares of common stock.
- Her total beneficial ownership of the December 7, 2023 RSU award is 923 units.
- Her total beneficial ownership of the December 5, 2024 RSU award is 2,263 units.
- Her total beneficial ownership of the December 4, 2025 RSU award is 7,094 units.
Sentiment
Score: 6
Explanation: The filing reports routine grants of restricted stock units to a key executive, which is a standard component of compensation and generally viewed as a positive for aligning management incentives with shareholder value. It does not contain any negative or unexpected information.
Positives
- The acquisition of Restricted Stock Units aligns the executive's long-term interests with those of shareholders, as the value of these units is tied to the company's stock performance.
- RSUs are a standard component of executive compensation, indicating ongoing commitment and retention of key management personnel.
Risks
- The value of the Restricted Stock Units is subject to market fluctuations of Hillenbrand's common stock.
- Vesting of RSUs is contingent upon continued employment and may be subject to performance conditions, which could impact the ultimate number of shares received.
Future Outlook
The Restricted Stock Units are scheduled to vest in one-third increments over three years, with the latest award (12/4/2025) vesting annually from December 4, 2026, through December 4, 2028. This indicates a long-term incentive structure for the executive.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, specifically the grant of equity compensation to a key executive. Such grants are common practice across industries to incentivize management and align their interests with long-term shareholder value. It does not provide specific insights into broader industry trends or competitive positioning beyond the company's standard compensation practices.
Stakeholder Impact
- Shareholders: The RSU grants align the interests of a key executive with shareholders, as the value of the compensation is tied to the company's stock performance.
- Employees: This reflects standard executive compensation practices, which can influence overall compensation philosophy within the company.
Next Steps
- The Restricted Stock Units will vest according to their respective schedules, converting into common stock upon meeting the vesting conditions.
- Future Form 4 filings will report any further changes in beneficial ownership by Megan A. Walke, including the vesting and conversion of these RSUs.
Key Dates
| Date | Description |
|---|---|
| 12/7/2023 | Original grant date for the first Restricted Stock Unit award. |
| 12/5/2024 | Original grant date for the second Restricted Stock Unit award. |
| 12/7/2024 | First vesting date for the 12/7/2023 RSU award (one-third). |
| 12/4/2025 | Original grant date for the third Restricted Stock Unit award. |
| 12/5/2025 | First vesting date for the 12/5/2024 RSU award (one-third). |
| 12/7/2025 | Second vesting date for the 12/7/2023 RSU award (one-third). |
| 12/31/2025 | Transaction date for the acquisition of the reported Restricted Stock Units. |
| 01/05/2026 | Signature date of the reporting person's attorney-in-fact on the filing. |
| 12/4/2026 | First vesting date for the 12/4/2025 RSU award (one-third). |
| 12/5/2026 | Second vesting date for the 12/5/2024 RSU award (one-third). |
| 12/7/2026 | Third and final vesting date for the 12/7/2023 RSU award (one-third). |
| 12/4/2027 | Second vesting date for the 12/4/2025 RSU award (one-third). |
| 12/5/2027 | Third and final vesting date for the 12/5/2024 RSU award (one-third). |
| 12/4/2028 | Third and final vesting date for the 12/4/2025 RSU award (one-third). |
Keywords
Hillenbrand, HI, Form 4, Restricted Stock Units, RSU, Insider Transaction, Beneficial Ownership, Executive Compensation, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.